The role of visfatin levels in gingival crevicular fluid as a potential biomarker in the relationship between obesity and periodontal disease

Detalhes bibliográficos
Autor(a) principal: Çetiner, Deniz
Data de Publicação: 2022
Outros Autores: Uraz, Ahu, Öztoprak, Seniha, Akça, Gülçin
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Journal of applied oral science (Online)
Texto Completo: https://www.revistas.usp.br/jaos/article/view/199692
Resumo: Objectives: Visfatin is an adipokine that plays an important role in immune functions as a growth factor, enzyme, and pro-inflammatory mediator. We aimed to determine the levels of visfatin, interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) in gingival crevicular fluid (GCF) in both obese/non-obese patients, with/without generalized chronic periodontitis (GCP). Methodology: Patients were categorized as obese (O) (n=31) or non-obese (nO) (n=19). Groups were divided into four subgroups according to periodontal conditions: (1) periodontally healthy without obesity (nO-Ctrl); (2) GCP without obesity (nO-CP); (3) periodontally healthy with obesity (O-Ctrl); and (4) GCP with obesity (O-CP). Demographic variables, anthropometric and laboratory data were recorded. Periodontal parameters were measured at baseline and 3rd months after either non-surgical periodontal treatment or calorie -restricted diet therapy. At the same time, GCF samples were taken from patients to analyze TNF-alpha, IL-6,and visfatin levels. Results: Periodontal parameters were significantly higher in the O group than in the nO group (P<0.05). IL-6 levels were higher in the O group than in the nO group (P<0.001). The visfatin levels of the obese patients were reduceddecreased following the treatments (P<0.05). Cholesterol levels were higher in the O group than in the nO groups (P<0.05). IL-6 levels were higher in O-CP and O-Ctrl groups than in the nO-Ctrl group (P<0.05). Compared to the other groups, visfatin levels were significantly higher in the O-CP group but decreased following treatment (P<0.05). Conclusions: Our findings suggest that visfatin and IL-6 levels in GCF are associated with the pathogenesis of obesity and periodontitis. Within the limits of this study, we considered that there might be an association between the lipid profile and periodontitis on systemically healthy individuals.
id USP-17_a4da8afdc2366fb6e2b64a479a4cd581
oai_identifier_str oai:revistas.usp.br:article/199692
network_acronym_str USP-17
network_name_str Journal of applied oral science (Online)
repository_id_str
spelling The role of visfatin levels in gingival crevicular fluid as a potential biomarker in the relationship between obesity and periodontal diseaseVisfatinChronic periodontitisObesityInterleukin-6Tumor necrosis factor alphaObjectives: Visfatin is an adipokine that plays an important role in immune functions as a growth factor, enzyme, and pro-inflammatory mediator. We aimed to determine the levels of visfatin, interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) in gingival crevicular fluid (GCF) in both obese/non-obese patients, with/without generalized chronic periodontitis (GCP). Methodology: Patients were categorized as obese (O) (n=31) or non-obese (nO) (n=19). Groups were divided into four subgroups according to periodontal conditions: (1) periodontally healthy without obesity (nO-Ctrl); (2) GCP without obesity (nO-CP); (3) periodontally healthy with obesity (O-Ctrl); and (4) GCP with obesity (O-CP). Demographic variables, anthropometric and laboratory data were recorded. Periodontal parameters were measured at baseline and 3rd months after either non-surgical periodontal treatment or calorie -restricted diet therapy. At the same time, GCF samples were taken from patients to analyze TNF-alpha, IL-6,and visfatin levels. Results: Periodontal parameters were significantly higher in the O group than in the nO group (P<0.05). IL-6 levels were higher in the O group than in the nO group (P<0.001). The visfatin levels of the obese patients were reduceddecreased following the treatments (P<0.05). Cholesterol levels were higher in the O group than in the nO groups (P<0.05). IL-6 levels were higher in O-CP and O-Ctrl groups than in the nO-Ctrl group (P<0.05). Compared to the other groups, visfatin levels were significantly higher in the O-CP group but decreased following treatment (P<0.05). Conclusions: Our findings suggest that visfatin and IL-6 levels in GCF are associated with the pathogenesis of obesity and periodontitis. Within the limits of this study, we considered that there might be an association between the lipid profile and periodontitis on systemically healthy individuals.Universidade de São Paulo. Faculdade de Odontologia de Bauru2022-07-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/jaos/article/view/19969210.1590/1678-7757-2018-0365Journal of Applied Oral Science; Vol. 27 (2019); e20180365Journal of Applied Oral Science; Vol. 27 (2019); e20180365Journal of Applied Oral Science; v. 27 (2019); e201803651678-77651678-7757reponame:Journal of applied oral science (Online)instname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/jaos/article/view/199692/183735Copyright (c) 2022 Journal of Applied Oral Sciencehttp://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessÇetiner, DenizUraz, AhuÖztoprak, SenihaAkça, Gülçin2022-07-01T13:48:21Zoai:revistas.usp.br:article/199692Revistahttp://www.scielo.br/jaosPUBhttps://www.revistas.usp.br/jaos/oai||jaos@usp.br1678-77651678-7757opendoar:2022-07-01T13:48:21Journal of applied oral science (Online) - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv The role of visfatin levels in gingival crevicular fluid as a potential biomarker in the relationship between obesity and periodontal disease
title The role of visfatin levels in gingival crevicular fluid as a potential biomarker in the relationship between obesity and periodontal disease
spellingShingle The role of visfatin levels in gingival crevicular fluid as a potential biomarker in the relationship between obesity and periodontal disease
Çetiner, Deniz
Visfatin
Chronic periodontitis
Obesity
Interleukin-6
Tumor necrosis factor alpha
title_short The role of visfatin levels in gingival crevicular fluid as a potential biomarker in the relationship between obesity and periodontal disease
title_full The role of visfatin levels in gingival crevicular fluid as a potential biomarker in the relationship between obesity and periodontal disease
title_fullStr The role of visfatin levels in gingival crevicular fluid as a potential biomarker in the relationship between obesity and periodontal disease
title_full_unstemmed The role of visfatin levels in gingival crevicular fluid as a potential biomarker in the relationship between obesity and periodontal disease
title_sort The role of visfatin levels in gingival crevicular fluid as a potential biomarker in the relationship between obesity and periodontal disease
author Çetiner, Deniz
author_facet Çetiner, Deniz
Uraz, Ahu
Öztoprak, Seniha
Akça, Gülçin
author_role author
author2 Uraz, Ahu
Öztoprak, Seniha
Akça, Gülçin
author2_role author
author
author
dc.contributor.author.fl_str_mv Çetiner, Deniz
Uraz, Ahu
Öztoprak, Seniha
Akça, Gülçin
dc.subject.por.fl_str_mv Visfatin
Chronic periodontitis
Obesity
Interleukin-6
Tumor necrosis factor alpha
topic Visfatin
Chronic periodontitis
Obesity
Interleukin-6
Tumor necrosis factor alpha
description Objectives: Visfatin is an adipokine that plays an important role in immune functions as a growth factor, enzyme, and pro-inflammatory mediator. We aimed to determine the levels of visfatin, interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) in gingival crevicular fluid (GCF) in both obese/non-obese patients, with/without generalized chronic periodontitis (GCP). Methodology: Patients were categorized as obese (O) (n=31) or non-obese (nO) (n=19). Groups were divided into four subgroups according to periodontal conditions: (1) periodontally healthy without obesity (nO-Ctrl); (2) GCP without obesity (nO-CP); (3) periodontally healthy with obesity (O-Ctrl); and (4) GCP with obesity (O-CP). Demographic variables, anthropometric and laboratory data were recorded. Periodontal parameters were measured at baseline and 3rd months after either non-surgical periodontal treatment or calorie -restricted diet therapy. At the same time, GCF samples were taken from patients to analyze TNF-alpha, IL-6,and visfatin levels. Results: Periodontal parameters were significantly higher in the O group than in the nO group (P<0.05). IL-6 levels were higher in the O group than in the nO group (P<0.001). The visfatin levels of the obese patients were reduceddecreased following the treatments (P<0.05). Cholesterol levels were higher in the O group than in the nO groups (P<0.05). IL-6 levels were higher in O-CP and O-Ctrl groups than in the nO-Ctrl group (P<0.05). Compared to the other groups, visfatin levels were significantly higher in the O-CP group but decreased following treatment (P<0.05). Conclusions: Our findings suggest that visfatin and IL-6 levels in GCF are associated with the pathogenesis of obesity and periodontitis. Within the limits of this study, we considered that there might be an association between the lipid profile and periodontitis on systemically healthy individuals.
publishDate 2022
dc.date.none.fl_str_mv 2022-07-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/jaos/article/view/199692
10.1590/1678-7757-2018-0365
url https://www.revistas.usp.br/jaos/article/view/199692
identifier_str_mv 10.1590/1678-7757-2018-0365
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/jaos/article/view/199692/183735
dc.rights.driver.fl_str_mv Copyright (c) 2022 Journal of Applied Oral Science
http://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2022 Journal of Applied Oral Science
http://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Odontologia de Bauru
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Odontologia de Bauru
dc.source.none.fl_str_mv Journal of Applied Oral Science; Vol. 27 (2019); e20180365
Journal of Applied Oral Science; Vol. 27 (2019); e20180365
Journal of Applied Oral Science; v. 27 (2019); e20180365
1678-7765
1678-7757
reponame:Journal of applied oral science (Online)
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Journal of applied oral science (Online)
collection Journal of applied oral science (Online)
repository.name.fl_str_mv Journal of applied oral science (Online) - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||jaos@usp.br
_version_ 1800221682620694528